Cancer treatment & research

Flatiron is revolutionizing cancer care by combining technology with vast oncological data to enhance treatment, research, and clinical trials. They provide clinicians, researchers, and regulators with the tools to learn quickly and improve care. With over 3.5 million de-identified patient records, Flatiron supports real-world evidence generation, helping to develop treatment strategies and regulatory submissions. Their platforms, such as Clinical Pipe and Flatiron Assist, streamline clinical workflows, facilitate evidence-based treatment decisions, and accelerate clinical research. They work towards closing the gap between care and research, ensuring efficient trials and aiding drug development with comprehensive insights from real-world data.

Flatiron

Flatiron improves cancer care through technology, research, and real-world evidence.

Drug discovery

Color offers a comprehensive cancer solution, in collaboration with the American Cancer Society, focusing on early detection and grounded in a before, during, and after diagnosis care continuum. They promote higher cancer screening adherence, resulting in early detection, which significantly impacts survival rates and reduces healthcare costs. With an integrated care system that streamlines care coordination, from screenings to diagnosis, and engagement through educational programming, Color aims to remove traditional healthcare barriers. Their services target employers, unions, brokers, and provide tailored, scalable solutions that increase the health outcomes for populations, while potentially saving on healthcare expenses.

Color

Comprehensive cancer detection and management solution partnered with ACS.

Cancer treatment & research

Similar spaces